161 related articles for article (PubMed ID: 35999136)
21. SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance.
Chen J; Gao Z; Li X; Shi Y; Tang Z; Liu W; Zhang X; Huang A; Luo X; Gao Q; Ding G; Song K; Zhou J; Fan J; Fu X; Ding Z
Cancer Med; 2023 Jan; 12(1):459-471. PubMed ID: 35676831
[TBL] [Abstract][Full Text] [Related]
22. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
[TBL] [Abstract][Full Text] [Related]
23. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
[TBL] [Abstract][Full Text] [Related]
24. Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma.
Yu WL; Yu G; Dong H; Chen K; Xie J; Yu H; Ji Y; Yang GS; Li AJ; Cong WM; Jin GZ
J Gastroenterol; 2020 Dec; 55(12):1171-1182. PubMed ID: 33089343
[TBL] [Abstract][Full Text] [Related]
25. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
26. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
[TBL] [Abstract][Full Text] [Related]
27. DCLK1 Expression and its Functional Significance in Intrahepatic Cholangiocarcinoma and Bil-IN Stage.
Fukushima NM; Adachi T; Tanaka T; Matsushima H; Imamura H; Hara T; Soyama A; Hidaka M; Kanetaka K; Eguchi S
Anticancer Res; 2024 Jun; 44(6):2417-2424. PubMed ID: 38821583
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
[TBL] [Abstract][Full Text] [Related]
29. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
Ohira S; Sasaki M; Harada K; Sato Y; Zen Y; Isse K; Kozaka K; Ishikawa A; Oda K; Nimura Y; Nakanuma Y
Am J Pathol; 2006 Apr; 168(4):1155-68. PubMed ID: 16565491
[TBL] [Abstract][Full Text] [Related]
30. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responses.
Liu B; Yan S; Jia Y; Ma J; Wu S; Xu Y; Shang M; Mao A
FEBS J; 2016 Oct; 283(20):3839-3850. PubMed ID: 27616304
[TBL] [Abstract][Full Text] [Related]
31. Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.
Li X; Yu C; Luo Y; Lin J; Wang F; Sun X; Gao Y; Tan W; Xia Q; Kong X
Int J Biol Sci; 2021; 17(7):1782-1794. PubMed ID: 33994862
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C.
Deng G; Teng Y; Huang F; Nie W; Zhu L; Huang W; Xu H
Mol Med Rep; 2015 Nov; 12(5):7079-85. PubMed ID: 26299768
[TBL] [Abstract][Full Text] [Related]
33. Apatinib Inhibits Angiogenesis in Intrahepatic Cholangiocarcinoma by Regulating the Vascular Endothelial Growth Factor Receptor-2/Signal Transducer and Activator of Transcription Factor 3/Hypoxia Inducible Factor 1 Subunit Alpha Signaling Axis.
Huang MP; Gu SZ; Huang B; Li GW; Xiong ZP; Tang T; Zeng SN
Pharmacology; 2021; 106(9-10):509-519. PubMed ID: 34412054
[TBL] [Abstract][Full Text] [Related]
34. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma.
Sueoka H; Hirano T; Uda Y; Iimuro Y; Yamanaka J; Fujimoto J
Surgery; 2014 Apr; 155(4):640-9. PubMed ID: 24582495
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
36. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis.
Lei GL; Li Z; Li YY; Hong ZX; Wang S; Bai ZF; Sun F; Yan J; Yu LX; Yang PH; Yang ZY
Environ Toxicol; 2021 Nov; 36(11):2322-2332. PubMed ID: 34418280
[TBL] [Abstract][Full Text] [Related]
38. EIF5A2 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells.
Yang SH; Hu S; Kang Q; Liu LX; Wei Q; Song ZM; Chen YH; Liao ZJ; Huan YF; Wang XJ; Zou H; Zhang XW
Clin Res Hepatol Gastroenterol; 2022; 46(7):101991. PubMed ID: 35792239
[TBL] [Abstract][Full Text] [Related]
39. UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway.
Zhang H; Yang J; Song Q; Ding X; Sun F; Yang L
Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):199-209. PubMed ID: 38298057
[TBL] [Abstract][Full Text] [Related]
40. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]